Profusa, Inc. Common Stock logo

Profusa, Inc. Common Stock

PFSA

NASDAQHealthcareMedical - Devices

Latest quote

$5.52

−$2.11 · -27.87%

Aug 21, 3:55 PM ET

PFSA company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

25

Expensive

Momentum

29

Weakening

Sentiment

50

Mixed

Risk resilience

34

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Profusa, Inc. is a pioneering health technology firm that engineers advanced, bio-integrated sensors. These innovative devices, exemplified by their Lumee™ Oxygen Platform, are designed for uninterrupted observation of internal physiological markers. By leveraging artificial intelligence, Profusa translates this constant stream of data into actionable health insights, primarily to empower individuals and clinicians in the management of persistent health challenges like diabetes and critical limb ischemia.

Industry
Medical - Devices
Sector
Healthcare
Headquarters
US
CEO
Jack E. Stover
Listed since
Jul 14, 2025
Employees
2

Market position

Volume
647.69K
6.28× average
Average volume
103.06K
Average daily volume
Market cap
6.02M USD
Beta
0.44
Market reference 1

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
276.17M USD
EV / EBITDA
-8.99×
Earnings yield
-13.61%
Free cash flow yield
-6.18%

Profitability & efficiency

Return on equity
134.38%
Return on assets
-948.95%
Return on invested capital
114.53%

Financial health

Current ratio
0.17×
Altman Z-score
-374.76
Piotroski F-score
2 of 9

Earnings

Latest fiscal-year EPS
-107.01
FY2025
Latest fiscal-year revenue
0 USD
FY2025

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend0.52-129.53-259.59-389.64FY21FY22FY23FY24FY25

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend0.10.03-0.03-0.1FY21FY22FY23FY24FY25

Corporate actions

Corporate action history

Stock split

Effective Aug 17, 2026

1:4

Stock split

Effective Jul 7, 2026

1:25

Stock split

Effective Feb 9, 2026

1:75

PFSA peers

Continue in GoAI

Research PFSA

research.disclaimer